Generic and Biosimilar Medications

Our core focus

Our core focus is to represent the views of the off-patent industry to increase understanding and awareness of the important role of generic and biosimilar medicines to the NHS and patients. The UK off-patent market is a success story, delivering critical savings and increasing patient access. It is vital that the operating environment is maintained and that government policy is supportive and encouraging. We want to foster a sustainable market in the UK which continues to deliver for patients and payors alike.

Working with our supply chain

We adopt a collaborative approach with our supply chain partners to ensure the right medicine reaches the right patient at the right time. Our work often involves partnering with colleagues across wholesale and pharmacy to ensure supply chains are effective and sustainable.

 

We also bring our deep industry knowledge to the close relationships we have with government and regulators. This ensures a balanced view on prospective policy and means there is increased understanding of the precise workings of the UK market.

Up